Highest-conviction names merged from Sector Rotation, Stage 2/VCP, and the Portfolio Strategy Lab best strategy, with deep technical · fundamental · risk-reward analysis.
| # | Symbol | Sector | Sub-sector | Price | Stage | Inv.Score | RS% | 6M Tgt | RR (4M) | Risk | Conviction | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GNA | EV & Auto Ancillaries | Auto Ancillaries | ₹562.85 | STAGE_2 | 73.10 | 97.6% | ₹742 | 1.74× | 1.5 | HIGH | VCP+Sector |
| 2 | ATHERENERG | EV & Auto Ancillaries | Auto Ancillaries | ₹1462.00 | STAGE_2 | 63.70 | 99.5% | ₹1,950 | 1.57× | 1.5 | MEDIUM | VCP+Sector |
| 3 | SONACOMS | EV & Auto Ancillaries | Auto Ancillaries | ₹817.60 | STAGE_2 | 70.30 | 97.5% | ₹1,008 | 1.02× | 0.5 | HIGH | VCP+Sector |
| 4 | HEG | Metals & Mining | Unmapped | ₹710.75 | STAGE_2 | 65.50 | 89.4% | ₹878 | 1.24× | 3.0 | MEDIUM | VCP+Sector |
| 5 | EICHERMOT | EV & Auto Ancillaries | Auto Ancillaries | ₹8010.00 | STAGE_2 | 70.20 | 72.9% | ₹9,777 | 1.99× | 2.0 | HIGH | VCP+Sector |
| 6 | ABB | Capital Goods & Industrials | Industrial Products | ₹— | — | — | — | ₹9,457 | 2.00× | 2.0 | MEDIUM | VCP+Sector |
| 7 | BAJAJ-AUTO | EV & Auto Ancillaries | Auto Ancillaries | ₹11700.00 | STAGE_2 | 72.50 | 81.7% | ₹14,093 | 1.31× | 3.5 | HIGH | VCP+Sector |
| 8 | SAILIFE | Metals & Mining | Unmapped | ₹1457.40 | STAGE_2 | 81.50 | 95.8% | ₹1,984 | 1.46× | 2.5 | HIGH | Sector+S2 |
| 9 | KEI | Capital Goods & Industrials | Industrial Products | ₹5527.60 | STAGE_2 | 79.30 | 81.0% | ₹7,339 | 2.00× | 2.5 | HIGH | Sector+S2 |
| 10 | NAVINFLUOR | Chemicals & Specialty | Specialty Chemicals | ₹8206.50 | STAGE_2 | 78.70 | 88.8% | ₹11,026 | 1.97× | 1.5 | HIGH | Sector+S2 |
Top picks are not selected from a single indicator. The report looks for names where market structure, sector strength, price action, strategy evidence, and risk/reward all point in the same direction.
scores.stage2_vcp_picks.The final rank balances Stage 2 trend quality, relative strength, sector leadership, VCP or breakout evidence, the swing research overlay, portfolio strategy confirmation, target/stop risk-reward, and fundamental quality. Triple-confirmed names where sector rotation + Stage 2/VCP + strategy evidence agree are prioritised, followed by dual-confirmed candidates with strong trend and acceptable risk.
A high-ranked pick is a research shortlist candidate, not a direct investment instruction. The strongest candidates combine Stage 2 structure, leadership versus the market, constructive sector context, defined stop-loss, and acceptable reward-to-risk.
Each card: candlestick chart with EMAs, S/R, pivots & entry/stop/targets · KPI tiles · LLM-narrated thesis · technicals · fundamentals · quarterly / annual / BS / CF · events · risk gauge.
GNA Axles is engaged in the Business of manufacturing auto components for the four-wheeler industry, primary product being Rear Axles, Shafts, Spindles & other Automobiles Components for sale in domestic and foreign market.
Source: Company website · screener.in · live
Stage-2 EMA stack (Price ₹563 > EMA20 > EMA50 > EMA200) · RS 98% vs Nifty 500 · Momentum RSI 61 · PAT YoY +65% · Revenue YoY +37% · OCF/PAT 1.62
RSI 60.6, 1Y return 82.2%, dist from 52w high -6.4%.
Latest qtr revenue 36.6% YoY, PAT 65.2% YoY; 4Y CAGR revenue 0.3% / PAT 0.4%; ROCE —%; debt trend stable; OCF/PAT 1.62.
Sector strength 95.14
Quantitative valuation not in dossier — defer to qualitative read.
Enter ₹543-₹563; stop ₹489; signal STRONG_BUY.
📐 EPS ₹30.8 × 14x (below-average quality / cyclical) = ₹431 median
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Synthesised consensus view (no live broker feed): the name screens as a turnaround / cyclical; buy-side would likely weight momentum + sector rotation; watch for re-rating triggers around the next quarterly print. Confirm against live broker reports before sizing.
| Closei | ₹562.85 (2026-08-21) |
| EMA 20/50/200i | ₹543.17 / ₹504.42 / ₹414.04 |
| EMA50 slope (20d)i | 10.93% |
| RSI(14)i | 60.62 |
| ATR(14)i | ₹25.62 (4.55%) |
| 52W High / Lowi | ₹601.65 / ₹291.80 |
| From 52W highi | -6.4% |
| Returns 1M/3M/6M/1Yi | 12.4% / 47.4% / 32.7% / 82.2% |
| Vol vs 20d avgi | 1.00x |
| Piotroski F-scorei | 5 / 6 (approx) |
| Altman Z-scorei | 3.17 (Z′ approx) |
| Beneish M-scorei | -2.66 (low, simplified) |
| Forensic riski | low (derived) |
| ROE / ROCEi | 13.1% (computed) / 15.6% (computed) |
| Revenue growth (3Y)i | 0.3% (4Y CAGR) |
| PAT growth (3Y)i | 0.4% (4Y CAGR) |
| Debt / Equityi | 0.22 (computed) |
| Promoter holdingi | 65.8% |
| FII / DII holdingi | 1.7% / 11.6% |
| NPMi | 8.2% (computed) |
| EPSi | 30.80 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹562.9 |
| EPS (TTM proxy)i | 30.80 |
| P/E (Screener ratios) | 18.3x |
| Market cap (Screener) | ₹2,416 Cr |
| Market-cap bucketi | MID_CAP |
| Book value | ₹234.0 |
| Dividend yield | 0.5% |
| Sales (latest)i | — |
| PAT (latest)i | ₹132 Cr (12.8% YoY) |
| Net debt (3Y)i | ₹218 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹543 – ₹563 |
| Stop loss | ₹489 |
| Target 2M | ₹640 |
| Target 4M | ₹691 |
| Target 6M | ₹742 |
| Reward / Risk (4M) | 1.74× |
| Reward / Risk (6M) | 2.44× |
| Risk per share | ₹74 |
| Suggested position size | 8% of portfolio |
Risk score breakdown: ATR 4.6% (+1.5)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 470 | 15 | 38 | 8.91 |
| Mar 2026 | 411 | 14 | 31 | 7.18 |
| Dec 2025 | 375 | 18 | 32 | 7.44 |
| Sep 2025 | 348 | 18 | 31 | 7.27 |
Rev QoQ +14.4% · YoY +36.6% · PAT QoQ +22.6% · YoY +65.2% · OPM vs 4Q avg -33 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 1605 | 16 | 132 | 30.80 |
| Mar 2026 | 1478 | 16 | 117 | 27.24 |
| Mar 2025 | 1540 | 14 | 107 | 24.94 |
| Mar 2024 | 1506 | 13 | 100 | 23.28 |
| Mar 2023 | 1583 | 15 | 130 | 30.35 |
4Y CAGR — Revenue 0.3% · PAT 0.4% · EPS 0.4%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 218 | 218 | 1520 |
| Mar 2025 | 259 | 259 | 1365 |
| Mar 2024 | 213 | 213 | 1219 |
Debt trend stable
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 214 | -155 | 59 |
| Mar 2025 | 92 | -111 | -19 |
| Mar 2024 | 98 | -86 | 12 |
OCF/PAT (latest FY) 1.62 → earnings quality: HIGH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: VCP-confirmed Stage 2 (vcp=83, inv=98.0) in top-ranked sector EV & Auto Ancillaries (strength=110) · 6 positive · 0 negative factors flagged
Incorporated in 2013, Ather Energy ltd is an Indian electric two-wheeler (E2W) company engaged in the design, development, and in-house assembly of electric scooters, battery packs, charging infrastructure, and supporting software systems [1]
Source: Company website · screener.in · live
Stage-2 EMA stack (Price ₹1462 > EMA20 > EMA50 > EMA200) · RS 100% vs Nifty 500 · Momentum RSI 61
RSI 61.3, 1Y return 235.4%, dist from 52w high -7.5%.
Latest qtr revenue —% YoY, PAT —% YoY; —Y CAGR revenue —% / PAT —%; ROCE -19.8%; debt trend —; OCF/PAT —.
Sector strength 95.14
Quantitative valuation not in dossier — defer to qualitative read.
Enter ₹1415-₹1462; stop ₹1239; signal STRONG_BUY.
📐 Mid-target from RR-engine 6m level (no EPS in dossier)
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Synthesised consensus view (no live broker feed): the name screens as a turnaround / cyclical; buy-side would likely weight momentum + sector rotation; watch for re-rating triggers around the next quarterly print. Confirm against live broker reports before sizing.
| Closei | ₹1462.00 (2026-08-21) |
| EMA 20/50/200i | ₹1415.21 / ₹1277.65 / ₹936.92 |
| EMA50 slope (20d)i | 16.92% |
| RSI(14)i | 61.28 |
| ATR(14)i | ₹69.71 (4.77%) |
| 52W High / Lowi | ₹1580.00 / ₹407.70 |
| From 52W highi | -7.5% |
| Returns 1M/3M/6M/1Yi | 18.6% / 53.8% / 99.3% / 235.4% |
| Vol vs 20d avgi | 0.36x |
| Piotroski F-scorei | — |
| Altman Z-scorei | — |
| Beneish M-scorei | — |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | -33.4% / -19.8% |
| Revenue growth (3Y)i | — |
| PAT growth (3Y)i | — |
| Debt / Equityi | — |
| Promoter holdingi | 39.6% |
| FII / DII holdingi | 16.8% / 29.8% |
| NPMi | -14.1% (computed) |
| EPSi | -13.51 (latest FY) |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹1,462.0 |
| EPS (TTM proxy)i | -13.51 |
| P/E (Screener ratios) | — |
| P/E (derived price ÷ EPS) | -108.2x |
| Market cap (Screener) | ₹57,675 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹67.2 |
| Dividend yield | 0.0% |
| Sales (latest)i | — |
| PAT (latest)i | — |
| Net debt (3Y)i | — |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹1,415 – ₹1,462 |
| Stop loss | ₹1,239 |
| Target 2M | ₹1,671 |
| Target 4M | ₹1,811 |
| Target 6M | ₹1,950 |
| Reward / Risk (4M) | 1.57× |
| Reward / Risk (6M) | 2.19× |
| Risk per share | ₹223 |
| Suggested position size | 8% of portfolio |
Risk score breakdown: ATR 4.8% (+1.5)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 1217 | -3 | -51 | -1.33 |
| Mar 2026 | 1175 | -6 | -100 | -2.62 |
| Jun 2025 | 645 | -21 | -178 | -4.79 |
Rev QoQ +3.6% · PAT QoQ -49.0% · OPM vs 4Q avg +1080 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Mar 2026 | 3672 | -11 | -517 | -13.51 |
No BS data.
No CF data.
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: VCP-confirmed Stage 2 (vcp=83, inv=95.7) in top-ranked sector EV & Auto Ancillaries (strength=110) · 3 positive · 0 negative factors flagged
Sona BLW Precision Forgings is an India-based automotive technology company. The company is engaged in designing, manufacturing and supplying engineered automotive systems and components such as differential assemblies, gears, conventional and micro-hybrid motors, BSG systems and EV Traction motors across all vehicle categories. The company develops mechanical and electrical hardware systems, components as well as base and application software solutions.
Source: Company website · screener.in · live
Stage-2 EMA stack (Price ₹818 > EMA20 > EMA50 > EMA200) · RS 98% vs Nifty 500 · Momentum RSI 69 · Within 5% of 52w high · PAT YoY +47% · Revenue YoY +52% · Net cash ₹108 Cr · OCF/PAT 0.96
RSI 68.6, 1Y return 79.6%, dist from 52w high -3.1%.
Latest qtr revenue 52.3% YoY, PAT 46.7% YoY; 4Y CAGR revenue 16.5% / PAT 14.8%; ROCE —%; debt trend stable; OCF/PAT 0.96.
Sector strength 95.14
Quantitative valuation not in dossier — defer to qualitative read.
Enter ₹787-₹818; stop ₹704; signal STRONG_BUY.
📐 EPS ₹11.2 × 14x (below-average quality / cyclical) = ₹157 median
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Synthesised consensus view (no live broker feed): the name screens as a turnaround / cyclical; buy-side would likely weight momentum + sector rotation; watch for re-rating triggers around the next quarterly print. Confirm against live broker reports before sizing.
| Closei | ₹817.60 (2026-08-21) |
| EMA 20/50/200i | ₹786.52 / ₹726.17 / ₹590.51 |
| EMA50 slope (20d)i | 13.24% |
| RSI(14)i | 68.56 |
| ATR(14)i | ₹23.09 (2.82%) |
| 52W High / Lowi | ₹844.00 / ₹402.30 |
| From 52W highi | -3.1% |
| Returns 1M/3M/6M/1Yi | 13.6% / 34.5% / 54.8% / 79.6% |
| Vol vs 20d avgi | 0.76x |
| Piotroski F-scorei | 2 / 6 (approx) |
| Altman Z-scorei | 3.89 (Z′ approx) |
| Beneish M-scorei | -2.46 (low, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 11.5% (computed) / 14.7% (computed) |
| Revenue growth (3Y)i | 16.5% (4Y CAGR) |
| PAT growth (3Y)i | 14.8% (4Y CAGR) |
| Debt / Equityi | 0.07 (computed) |
| Promoter holdingi | 28.0% |
| FII / DII holdingi | 23.6% / 41.6% |
| NPMi | 14.0% (computed) |
| EPSi | 11.20 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹817.6 |
| EPS (TTM proxy)i | 11.20 |
| P/E (Screener ratios) | 70.2x |
| P/E (derived price ÷ EPS) | 73.0x |
| Market cap (Screener) | ₹51,009 Cr |
| Market-cap bucketi | MID_CAP |
| Book value | ₹96.2 |
| Dividend yield | 0.4% |
| Sales (latest)i | — |
| PAT (latest)i | ₹686 Cr (9.1% YoY) |
| Net debt (3Y)i | ₹-108 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹787 – ₹818 |
| Stop loss | ₹704 |
| Target 2M | ₹887 |
| Target 4M | ₹933 |
| Target 6M | ₹1,008 |
| Reward / Risk (4M) | 1.02× |
| Reward / Risk (6M) | 1.68× |
| Risk per share | ₹113 |
| Suggested position size | 8% of portfolio |
Risk score breakdown: ATR 2.8% (+0.5)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 1301 | 23 | 179 | 2.90 |
| Mar 2026 | 1258 | 24 | 187 | 3.09 |
| Dec 2025 | 1200 | 25 | 150 | 2.43 |
| Sep 2025 | 1138 | 25 | 170 | 2.78 |
Rev QoQ +3.4% · YoY +52.3% · PAT QoQ -4.3% · YoY +46.7% · OPM vs 4Q avg -233 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 4897 | 24 | 686 | 11.20 |
| Mar 2026 | 4449 | 24 | 629 | 10.29 |
| Mar 2025 | 3546 | 27 | 600 | 9.67 |
| Mar 2024 | 3185 | 28 | 518 | 8.82 |
| Mar 2023 | 2655 | 25 | 395 | 6.75 |
4Y CAGR — Revenue 16.5% · PAT 14.8% · EPS 13.5%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 442 | -108 | 7464 |
| Mar 2025 | 202 | -662 | 6537 |
| Mar 2024 | 412 | 370 | 3865 |
Debt trend stable · Net cash positive
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 659 | -1554 | -895 |
| Mar 2025 | 775 | -1762 | -987 |
| Mar 2024 | 693 | -471 | 222 |
OCF/PAT (latest FY) 0.96 → earnings quality: HIGH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: VCP-confirmed Stage 2 (vcp=87, inv=95.3) in top-ranked sector EV & Auto Ancillaries (strength=110) · 8 positive · 0 negative factors flagged
HEG Ltd is a leading manufacturer and exporter of graphite electrodes in India. It operates the largest single-site integrated graphite electrodes plant in the world. [1] It is a part of LNJ Bhilwara Group which also has presence across IT Enabled services, power generation & textiles. [2]
Source: Company website · screener.in · live
Stage-2 EMA stack (Price ₹711 > EMA20 > EMA50 > EMA200) · RS 89% vs Nifty 500 · Momentum RSI 65 · Net cash ₹682 Cr
RSI 65.0, 1Y return 39.5%, dist from 52w high -5.1%.
Latest qtr revenue 11.1% YoY, PAT 16.2% YoY; 4Y CAGR revenue 1.7% / PAT -9.4%; ROCE —%; debt trend rising; OCF/PAT 0.59.
Sector strength 92.39
Quantitative valuation not in dossier — defer to qualitative read.
Enter ₹679-₹711; stop ₹614; signal BUY.
📐 EPS ₹18.6 × 14x (below-average quality / cyclical) = ₹260 median
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Synthesised consensus view (no live broker feed): the name screens as a turnaround / cyclical; buy-side would likely weight momentum + sector rotation; watch for re-rating triggers around the next quarterly print. Confirm against live broker reports before sizing.
| Closei | ₹710.75 (2026-08-21) |
| EMA 20/50/200i | ₹678.69 / ₹632.90 / ₹572.68 |
| EMA50 slope (20d)i | 11.99% |
| RSI(14)i | 65.01 |
| ATR(14)i | ₹23.92 (3.37%) |
| 52W High / Lowi | ₹749.00 / ₹459.80 |
| From 52W highi | -5.1% |
| Returns 1M/3M/6M/1Yi | 13.9% / 21.0% / 30.2% / 39.5% |
| Vol vs 20d avgi | 0.50x |
| Piotroski F-scorei | 2 / 6 (approx) |
| Altman Z-scorei | 3.20 (Z′ approx) |
| Beneish M-scorei | -2.05 (watch, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 7.5% (computed) / 8.7% (computed) |
| Revenue growth (3Y)i | 1.7% (4Y CAGR) |
| PAT growth (3Y)i | -9.4% (4Y CAGR) |
| Debt / Equityi | 0.17 (computed) |
| Promoter holdingi | 56.3% |
| FII / DII holdingi | 8.5% / 9.3% |
| NPMi | 13.6% (computed) |
| EPSi | 18.60 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹710.8 |
| EPS (TTM proxy)i | 18.60 |
| P/E (Screener ratios) | 38.7x |
| Market cap (Screener) | ₹13,716 Cr |
| Market-cap bucketi | MID_CAP |
| Book value | ₹247.0 |
| Dividend yield | 0.5% |
| Sales (latest)i | — |
| PAT (latest)i | ₹359 Cr (5.3% YoY) |
| Net debt (3Y)i | ₹-682 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹679 – ₹711 |
| Stop loss | ₹614 |
| Target 2M | ₹783 |
| Target 4M | ₹830 |
| Target 6M | ₹878 |
| Reward / Risk (4M) | 1.24× |
| Reward / Risk (6M) | 1.73× |
| Risk per share | ₹97 |
| Suggested position size | 8% of portfolio |
Risk score breakdown: ATR 3.4% (+1.5) · Debt rising (+1.0) · OCF/PAT watch (+0.5)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 681 | 22 | 122 | 6.34 |
| Mar 2026 | 603 | -25 | -114 | -5.90 |
| Dec 2025 | 656 | 22 | 207 | 10.73 |
| Sep 2025 | 699 | 17 | 143 | 7.43 |
Rev QoQ +12.9% · YoY +11.1% · PAT QoQ -207.0% · YoY +16.2% · OPM vs 4Q avg +1633 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 2639 | 10 | 359 | 18.60 |
| Mar 2026 | 2568 | 16 | 341 | 17.69 |
| Mar 2025 | 2151 | 12 | 115 | 5.96 |
| Mar 2024 | 2393 | 16 | 312 | 16.15 |
| Mar 2023 | 2463 | 25 | 532 | 27.59 |
4Y CAGR — Revenue 1.7% · PAT -9.4% · EPS -9.4%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 796 | -682 | 6166 |
| Mar 2025 | 588 | -812 | 5648 |
| Mar 2024 | 623 | -577 | 5701 |
Debt trend rising · Net cash positive
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 213 | -320 | -107 |
| Mar 2025 | 280 | -207 | 73 |
| Mar 2024 | 612 | -184 | 428 |
OCF/PAT (latest FY) 0.59 → earnings quality: WATCH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: VCP-confirmed Stage 2 (vcp=79, inv=90.0) in top-ranked sector Metals & Mining (strength=107) · 4 positive · 1 negative factors flagged
Eicher Motors Limited, incorporated in 1982, is the listed company of the Eicher Group in India and a leading player in the Indian automobile industry and the global leader in middleweight motorcycles. Eicher has a joint venture with Sweden’s AB Volvo to create Volvo Eicher Commercial Vehicles Limited (VECV). VECV is engaged in truck and bus operations, auto components business, and technical consulting services business [1]
Source: Company website · screener.in · live
Stage-2 EMA stack (Price ₹8010 > EMA20 > EMA50 > EMA200) · RS 73% vs Nifty 500 · Within 5% of 52w high · PAT YoY +21% · Revenue YoY +32% · Net cash ₹16982 Cr · OCF/PAT 0.83
RSI 58.8, 1Y return 34.9%, dist from 52w high -2.7%.
Latest qtr revenue 31.5% YoY, PAT 21.4% YoY; 4Y CAGR revenue 14.7% / PAT 18.6%; ROCE —%; debt trend rising; OCF/PAT 0.83.
Sector strength 95.14
Quantitative valuation not in dossier — defer to qualitative read.
Enter ₹7934-₹8010; stop ₹7486; signal BUY.
📐 EPS ₹210.4 × 14x (below-average quality / cyclical) = ₹2,946 median
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Synthesised consensus view (no live broker feed): the name screens as a turnaround / cyclical; buy-side would likely weight momentum + sector rotation; watch for re-rating triggers around the next quarterly print. Confirm against live broker reports before sizing.
| Closei | ₹8010.00 (2026-08-21) |
| EMA 20/50/200i | ₹7934.29 / ₹7717.28 / ₹7310.78 |
| EMA50 slope (20d)i | 4.44% |
| RSI(14)i | 58.77 |
| ATR(14)i | ₹122.00 (1.52%) |
| 52W High / Lowi | ₹8230.00 / ₹5880.00 |
| From 52W highi | -2.7% |
| Returns 1M/3M/6M/1Yi | 3.7% / 8.6% / 1.4% / 34.9% |
| Vol vs 20d avgi | 0.65x |
| Piotroski F-scorei | 3 / 6 (approx) |
| Altman Z-scorei | 4.20 (Z′ approx) |
| Beneish M-scorei | -2.29 (low, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 23.0% (computed) / 29.3% (computed) |
| Revenue growth (3Y)i | 14.7% (4Y CAGR) |
| PAT growth (3Y)i | 18.6% (4Y CAGR) |
| Debt / Equityi | 0.02 (computed) |
| Promoter holdingi | 49.0% |
| FII / DII holdingi | 25.5% / 16.0% |
| NPMi | 23.1% (computed) |
| EPSi | 210.41 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹8,010.0 |
| EPS (TTM proxy)i | 210.41 |
| P/E (Screener ratios) | 37.8x |
| Market cap (Screener) | ₹219,892 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹915.0 |
| Dividend yield | 1.0% |
| Sales (latest)i | — |
| PAT (latest)i | — |
| Net debt (3Y)i | ₹-16,982 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹7,934 – ₹8,010 |
| Stop loss | ₹7,486 |
| Target 2M | ₹8,376 |
| Target 4M | ₹9,053 |
| Target 6M | ₹9,777 |
| Reward / Risk (4M) | 1.99× |
| Reward / Risk (6M) | 3.37× |
| Risk per share | ₹524 |
| Suggested position size | 8% of portfolio |
Risk score breakdown: Near high -2.7% (+1.0) · Debt rising (+1.0)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 6632 | 24 | 1463 | 53.28 |
| Mar 2026 | 6080 | 25 | 1520 | 55.41 |
| Dec 2025 | 6114 | 25 | 1421 | 51.79 |
| Sep 2025 | 6172 | 24 | 1369 | 49.93 |
Rev QoQ +9.1% · YoY +31.5% · PAT QoQ -3.8% · YoY +21.4% · OPM vs 4Q avg -33 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 24998 | 25 | 5773 | 210.41 |
| Mar 2026 | 23408 | 25 | 5515 | 201.06 |
| Mar 2025 | 18870 | 25 | 4734 | 172.69 |
| Mar 2024 | 16536 | 26 | 4001 | 146.13 |
| Mar 2023 | 14442 | 24 | 2914 | 106.55 |
4Y CAGR — Revenue 14.7% · PAT 18.6% · EPS 18.5%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 514 | -16982 | 32164 |
| Mar 2025 | 458 | -14333 | 27174 |
| Mar 2024 | 419 | -13108 | 23115 |
Debt trend rising · Net cash positive
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 4805 | -2834 | 1971 |
| Mar 2025 | 3980 | -2461 | 1519 |
| Mar 2024 | 3724 | -2834 | 890 |
OCF/PAT (latest FY) 0.83 → earnings quality: HIGH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: VCP-confirmed Stage 2 (vcp=86, inv=90.0) in top-ranked sector EV & Auto Ancillaries (strength=110) · 7 positive · 1 negative factors flagged
ABB India Limited is an integrated power equipment manufacturer supplying the complete range of engineering, products, solutions and services in areas of Automation and Power technology. [1]
Source: Company website · screener.in · live
Revenue YoY +21% · PAT 4Y CAGR 100% · ROCE 30% · ROE 22%
RSI 47.9, 1Y return 46.5%, dist from 52w high -6.3%.
Latest qtr revenue 21.1% YoY, PAT 2.8% YoY; 4Y CAGR revenue 16.0% / PAT 100.5%; ROCE 30.0%; debt trend rising; OCF/PAT 0.41.
Sector strength 89.06
Quantitative valuation not in dossier — defer to qualitative read.
Enter ₹7344-₹7424; stop ₹7024; signal HOLD.
📐 EPS ₹78.7 × 35x (premium-quality compounder) = ₹2,756 median
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Synthesised consensus view (no live broker feed): the name screens as a high-quality compounder; buy-side would likely weight mean-reversion; watch for re-rating triggers around the next quarterly print. Confirm against live broker reports before sizing.
| Closei | ₹7424.00 (2026-08-21) |
| EMA 20/50/200i | ₹7509.01 / ₹7323.53 / ₹6389.98 |
| EMA50 slope (20d)i | 3.85% |
| RSI(14)i | 47.86 |
| ATR(14)i | ₹159.82 (2.15%) |
| 52W High / Lowi | ₹7924.50 / ₹4637.50 |
| From 52W highi | -6.3% |
| Returns 1M/3M/6M/1Yi | -1.4% / 9.1% / 29.8% / 46.5% |
| Vol vs 20d avgi | 0.28x |
| Piotroski F-scorei | 3 / 6 (approx) |
| Altman Z-scorei | 3.08 (Z′ approx) |
| Beneish M-scorei | -1.89 (watch, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 22.4% / 30.0% |
| Revenue growth (3Y)i | 16.0% (4Y CAGR) |
| PAT growth (3Y)i | 100.5% (4Y CAGR) |
| Debt / Equityi | 0.02 (computed) |
| Promoter holdingi | 75.0% |
| FII / DII holdingi | 7.7% / 9.9% |
| NPMi | 12.6% |
| EPSi | 78.73 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | — |
| EPS (TTM proxy)i | 78.73 |
| P/E (Screener ratios) | 105.0x |
| Market cap (Screener) | ₹162,089 Cr |
| Market-cap bucketi | — |
| Book value | ₹441.0 |
| Dividend yield | 0.5% |
| Sales (latest)i | ₹13,203 Cr (8.3% YoY) |
| PAT (latest)i | ₹1,668 Cr (-10.9% YoY) |
| Net debt (3Y)i | ₹143 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹7,344 – ₹7,424 |
| Stop loss | ₹7,024 |
| Target 2M | ₹7,903 |
| Target 4M | ₹8,223 |
| Target 6M | ₹9,457 |
| Reward / Risk (4M) | 2.00× |
| Reward / Risk (6M) | 5.09× |
| Risk per share | ₹400 |
| Suggested position size | 8% of portfolio |
Risk score breakdown: ATR 2.2% (+0.5) · Debt rising (+1.0) · OCF/PAT watch (+0.5)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 3559 | 13 | 362 | 17.10 |
| Mar 2026 | 3184 | 13 | 1784 | 84.17 |
| Dec 2025 | 3423 | 15 | 433 | 20.43 |
| Sep 2025 | 3311 | 15 | 409 | 19.30 |
Rev QoQ +11.8% · YoY +21.1% · PAT QoQ -79.7% · YoY +2.8% · OPM vs 4Q avg -300 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 13477 | 14 | 2988 | 141.00 |
| Dec 2025 | 13203 | 15 | 1668 | 78.73 |
| Dec 2024 | 12188 | 19 | 1872 | 88.33 |
| Dec 2012 | 7608 | 5 | 141 | 6.65 |
| Dec 2011 | 7449 | 5 | 185 | 8.72 |
4Y CAGR — Revenue 16.0% · PAT 100.5% · EPS 100.5%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Jun 2026 | 145 | 143 | 15736 |
| Dec 2025 | 85 | 83 | 13638 |
| Dec 2024 | 52 | 50 | 12391 |
Debt trend rising
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Dec 2025 | 1220 | 364 | 1584 |
| Dec 2024 | 1332 | -503 | 829 |
| Dec 2012 | -44 | -340 | -384 |
OCF/PAT (latest FY) 0.41 → earnings quality: WATCH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: VCP-confirmed Stage 2 (vcp=80, inv=88.5) in top-ranked sector Capital Goods & Industrials (strength=94) · 4 positive · 1 negative factors flagged
Bajaj Auto, the flagship company of Bajaj Group, is a two-wheeler and three-wheeler manufacturing company that exports to 79 countries across several countries in Latin America, Southeast Asia, and many more. Its headquarter is in Pune, India. It has acquired 48% of the KTM Brand which manufactures sports and super sports two-wheelers, which was 14% in 2007 when the company first acquired KTM. [1]
Source: Company website · screener.in · live
Stage-2 EMA stack (Price ₹11700 > EMA20 > EMA50 > EMA200) · RS 82% vs Nifty 500 · Momentum RSI 63 · Within 5% of 52w high · PAT YoY +44% · Revenue YoY +65% · Net cash ₹1929 Cr
RSI 62.8, 1Y return 33.0%, dist from 52w high -1.4%.
Latest qtr revenue 65.1% YoY, PAT 44.3% YoY; 4Y CAGR revenue 18.3% / PAT 17.5%; ROCE —%; debt trend rising; OCF/PAT 0.22.
Sector strength 95.14
Quantitative valuation not in dossier — defer to qualitative read.
Enter ₹11496-₹11700; stop ₹10672; signal STRONG_BUY.
📐 EPS ₹420.8 × 14x (below-average quality / cyclical) = ₹5,891 median
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Synthesised consensus view (no live broker feed): the name screens as a turnaround / cyclical; buy-side would likely weight momentum + sector rotation; watch for re-rating triggers around the next quarterly print. Confirm against live broker reports before sizing.
| Closei | ₹11700.00 (2026-08-21) |
| EMA 20/50/200i | ₹11495.63 / ₹11002.27 / ₹9974.14 |
| EMA50 slope (20d)i | 7.58% |
| RSI(14)i | 62.83 |
| ATR(14)i | ₹185.36 (1.58%) |
| 52W High / Lowi | ₹11863.00 / ₹8491.50 |
| From 52W highi | -1.4% |
| Returns 1M/3M/6M/1Yi | 3.7% / 10.5% / 20.3% / 33.0% |
| Vol vs 20d avgi | 0.87x |
| Piotroski F-scorei | 2 / 6 (approx) |
| Altman Z-scorei | 2.61 (Z′ approx) |
| Beneish M-scorei | -1.96 (watch, simplified) |
| Forensic riski | high (derived) |
| ROE / ROCEi | 29.8% (computed) / 27.2% (computed) |
| Revenue growth (3Y)i | 18.3% (4Y CAGR) |
| PAT growth (3Y)i | 17.5% (4Y CAGR) |
| Debt / Equityi | 0.58 (computed) |
| Promoter holdingi | 55.0% |
| FII / DII holdingi | 9.0% / 13.4% |
| NPMi | 16.2% (computed) |
| EPSi | 420.80 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹11,700.0 |
| EPS (TTM proxy)i | 420.80 |
| P/E (Screener ratios) | 27.4x |
| Market cap (Screener) | ₹322,553 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹1.0 |
| Dividend yield | 1.3% |
| Sales (latest)i | — |
| PAT (latest)i | — |
| Net debt (3Y)i | ₹-1,929 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹11,496 – ₹11,700 |
| Stop loss | ₹10,672 |
| Target 2M | ₹12,256 |
| Target 4M | ₹13,049 |
| Target 6M | ₹14,093 |
| Reward / Risk (4M) | 1.31× |
| Reward / Risk (6M) | 2.33× |
| Risk per share | ₹1,028 |
| Suggested position size | 8% of portfolio |
Risk score breakdown: Near high -1.4% (+1.0) · Debt rising (+1.0) · OCF/PAT weak (+1.5)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 21689 | 21 | 3189 | 115.41 |
| Mar 2026 | 17832 | 17 | 3492 | 131.02 |
| Dec 2025 | 16204 | 23 | 2750 | 98.38 |
| Sep 2025 | 15735 | 18 | 2122 | 75.99 |
Rev QoQ +21.6% · YoY +65.1% · PAT QoQ -8.7% · YoY +44.3% · OPM vs 4Q avg +117 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 71460 | 20 | 11553 | 420.80 |
| Mar 2026 | 62905 | 21 | 10574 | 384.41 |
| Mar 2025 | 50995 | 19 | 7325 | 262.29 |
| Mar 2024 | 44870 | 20 | 7708 | 276.10 |
| Mar 2023 | 36455 | 18 | 6060 | 214.17 |
4Y CAGR — Revenue 18.3% · PAT 17.5% · EPS 18.4%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 22713 | -1929 | 76914 |
| Mar 2025 | 9364 | -19550 | 54110 |
| Mar 2024 | 1912 | -26175 | 39344 |
Debt trend rising · Net cash positive
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 2597 | -7018 | -4421 |
| Mar 2025 | -1406 | -1053 | -2459 |
| Mar 2024 | 6558 | -72 | 6486 |
OCF/PAT (latest FY) 0.22 → earnings quality: WEAK
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: VCP-confirmed Stage 2 (vcp=89, inv=87.4) in top-ranked sector EV & Auto Ancillaries (strength=110) · 7 positive · 2 negative factors flagged
Incorporated in 1999, Sai Life Sciences Ltd carries out contract research and manufacturing activities for customers engaged in pharmaceutical and bio technology industries [1]
Source: Company website · screener.in · live
Stage-2 EMA stack (Price ₹1457 > EMA20 > EMA50 > EMA200) · RS 96% vs Nifty 500 · Momentum RSI 64 · Within 5% of 52w high · PAT YoY +22% · PAT 4Y CAGR 145% · OCF/PAT 1.41
RSI 64.1, 1Y return 60.0%, dist from 52w high -1.9%.
Latest qtr revenue 11.7% YoY, PAT 21.7% YoY; 4Y CAGR revenue 16.6% / PAT 145.3%; ROCE 14.0%; debt trend falling; OCF/PAT 1.41.
Sector strength 92.39
Quantitative valuation not in dossier — defer to qualitative read.
Enter ₹1397-₹1457; stop ₹1274; signal STRONG_BUY.
📐 EPS ₹15.9 × 35x (premium-quality compounder) = ₹556 median
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Synthesised consensus view (no live broker feed): the name screens as a turnaround / cyclical; buy-side would likely weight momentum + sector rotation; watch for re-rating triggers around the next quarterly print. Confirm against live broker reports before sizing.
| Closei | ₹1457.40 (2026-08-21) |
| EMA 20/50/200i | ₹1396.78 / ₹1313.43 / ₹1095.60 |
| EMA50 slope (20d)i | 9.30% |
| RSI(14)i | 64.14 |
| ATR(14)i | ₹53.56 (3.68%) |
| 52W High / Lowi | ₹1485.00 / ₹783.85 |
| From 52W highi | -1.9% |
| Returns 1M/3M/6M/1Yi | 17.5% / 27.7% / 55.6% / 60.0% |
| Vol vs 20d avgi | 0.57x |
| Piotroski F-scorei | 4 / 6 (approx) |
| Altman Z-scorei | 2.99 (Z′ approx) |
| Beneish M-scorei | -2.64 (low, simplified) |
| Forensic riski | low (derived) |
| ROE / ROCEi | 14.9% / 14.0% |
| Revenue growth (3Y)i | 16.6% (4Y CAGR) |
| PAT growth (3Y)i | 145.3% (4Y CAGR) |
| Debt / Equityi | 0.12 (computed) |
| Promoter holdingi | 34.5% |
| FII / DII holdingi | 19.6% / 32.7% |
| NPMi | 15.3% |
| EPSi | 15.89 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹1,457.4 |
| EPS (TTM proxy)i | 15.89 |
| P/E (Screener ratios) | 83.4x |
| P/E (derived price ÷ EPS) | 91.7x |
| Market cap (Screener) | ₹30,069 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹118.0 |
| Dividend yield | 0.0% |
| Sales (latest)i | ₹2,170 Cr (28.0% YoY) |
| PAT (latest)i | ₹333 Cr (95.9% YoY) |
| Net debt (3Y)i | ₹238 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹1,397 – ₹1,457 |
| Stop loss | ₹1,274 |
| Target 2M | ₹1,618 |
| Target 4M | ₹1,725 |
| Target 6M | ₹1,984 |
| Reward / Risk (4M) | 1.46× |
| Reward / Risk (6M) | 2.87× |
| Risk per share | ₹183 |
| Suggested position size | 8% of portfolio |
Risk score breakdown: ATR 3.7% (+1.5) · Near high -1.9% (+1.0)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 554 | 27 | 73 | 3.45 |
| Mar 2026 | 602 | 29 | 104 | 4.92 |
| Dec 2025 | 556 | 34 | 100 | 4.75 |
| Sep 2025 | 537 | 27 | 84 | 4.00 |
Rev QoQ -8.0% · YoY +11.7% · PAT QoQ -29.8% · YoY +21.7% · OPM vs 4Q avg -100 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 2250 | 29 | 362 | 17.12 |
| Mar 2026 | 2192 | 29 | 349 | 16.48 |
| Mar 2025 | 1695 | 24 | 170 | 8.16 |
| Mar 2024 | 1465 | 20 | 83 | — |
| Mar 2023 | 1217 | 14 | 10 | — |
4Y CAGR — Revenue 16.6% · PAT 145.3% · EPS —
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 288 | 238 | 3626 |
| Mar 2025 | 352 | 350 | 3146 |
| Mar 2024 | 928 | 926 | 2262 |
Debt trend falling
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 509 | -395 | 114 |
| Mar 2025 | 314 | -536 | -222 |
| Mar 2024 | 263 | -191 | 72 |
OCF/PAT (latest FY) 1.41 → earnings quality: HIGH
Why selected: Stage 2 leader in top sector Metals & Mining (strength=107), inv=81.5 · 7 positive · 0 negative factors flagged
Incorporated in 1968, KEI Industries Ltd manufactures wires and cables (W&C) like EHV cables, HT cables, LT cables, and sells them in India and overseas [1]
Source: Company website · screener.in · live
Stage-2 EMA stack (Price ₹5528 > EMA20 > EMA50 > EMA200) · RS 81% vs Nifty 500 · PAT YoY +40% · Revenue YoY +23% · PAT 4Y CAGR 20% · OCF/PAT 0.84 · ROCE 20%
RSI 53.5, 1Y return 40.1%, dist from 52w high -6.3%.
Latest qtr revenue 23.0% YoY, PAT 39.8% YoY; 4Y CAGR revenue 15.6% / PAT 20.2%; ROCE 20.0%; debt trend rising; OCF/PAT 0.84.
Sector strength 89.06
Quantitative valuation not in dossier — defer to qualitative read.
Enter ₹5442-₹5528; stop ₹5101; signal BUY.
📐 EPS ₹96.1 × 25x (quality growth) = ₹2,402 median
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Synthesised consensus view (no live broker feed): the name screens as a high-quality compounder; buy-side would likely weight momentum + sector rotation; watch for re-rating triggers around the next quarterly print. Confirm against live broker reports before sizing.
| Closei | ₹5527.60 (2026-08-21) |
| EMA 20/50/200i | ₹5512.91 / ₹5330.87 / ₹4789.27 |
| EMA50 slope (20d)i | 4.15% |
| RSI(14)i | 53.54 |
| ATR(14)i | ₹170.79 (3.09%) |
| 52W High / Lowi | ₹5899.00 / ₹3728.70 |
| From 52W highi | -6.3% |
| Returns 1M/3M/6M/1Yi | 12.9% / 4.2% / 21.0% / 40.1% |
| Vol vs 20d avgi | 0.55x |
| Piotroski F-scorei | 3 / 6 (approx) |
| Altman Z-scorei | 4.23 (Z′ approx) |
| Beneish M-scorei | -2.50 (low, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 14.8% / 20.0% |
| Revenue growth (3Y)i | 15.6% (4Y CAGR) |
| PAT growth (3Y)i | 20.2% (4Y CAGR) |
| Debt / Equityi | 0.04 (computed) |
| Promoter holdingi | 35.0% |
| FII / DII holdingi | 27.3% / 25.9% |
| NPMi | 7.8% |
| EPSi | 96.07 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹5,527.6 |
| EPS (TTM proxy)i | 96.07 |
| P/E (Screener ratios) | 53.0x |
| P/E (derived price ÷ EPS) | 57.5x |
| Market cap (Screener) | ₹52,844 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹697.0 |
| Dividend yield | 0.1% |
| Sales (latest)i | ₹11,748 Cr (20.7% YoY) |
| PAT (latest)i | ₹918 Cr (31.9% YoY) |
| Net debt (3Y)i | ₹251 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹5,442 – ₹5,528 |
| Stop loss | ₹5,101 |
| Target 2M | ₹6,040 |
| Target 4M | ₹6,382 |
| Target 6M | ₹7,339 |
| Reward / Risk (4M) | 2.00× |
| Reward / Risk (6M) | 4.24× |
| Risk per share | ₹427 |
| Suggested position size | 8% of portfolio |
Risk score breakdown: ATR 3.1% (+1.5) · Debt rising (+1.0)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 3185 | 12 | 274 | 28.68 |
| Mar 2026 | 3476 | 11 | 284 | 29.74 |
| Dec 2025 | 2955 | 11 | 235 | 24.57 |
| Sep 2025 | 2726 | 10 | 204 | 21.29 |
Rev QoQ -8.4% · YoY +23.0% · PAT QoQ -3.5% · YoY +39.8% · OPM vs 4Q avg +167 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 12343 | 11 | 997 | 104.28 |
| Mar 2026 | 11748 | 10 | 918 | 96.07 |
| Mar 2025 | 9736 | 10 | 696 | 72.88 |
| Mar 2024 | 8104 | 10 | 581 | 64.35 |
| Mar 2023 | 6912 | 10 | 477 | 52.93 |
4Y CAGR — Revenue 15.6% · PAT 20.2% · EPS 18.5%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 253 | 251 | 8956 |
| Mar 2025 | 217 | 215 | 7235 |
| Mar 2024 | 166 | 164 | 4656 |
Debt trend rising
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 840 | -350 | 490 |
| Mar 2025 | -32 | -1501 | -1533 |
| Mar 2024 | 610 | -353 | 257 |
OCF/PAT (latest FY) 0.84 → earnings quality: HIGH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: Stage 2 leader in top sector Capital Goods & Industrials (strength=94), inv=79.3 · 7 positive · 1 negative factors flagged
Navin Fluorine International Ltd is primary engaged in producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers contract research and manufacturing services. [1] Its portfolio includes 50+ fluorinated compounds developed over the years. [2]
Source: Company website · screener.in · live
Stage-2 EMA stack (Price ₹8206 > EMA20 > EMA50 > EMA200) · RS 89% vs Nifty 500 · PAT YoY +108% · Revenue YoY +44% · PAT 4Y CAGR 20% · OCF/PAT 1.13 · ROCE 21%
RSI 57.0, 1Y return 62.7%, dist from 52w high -6.5%.
Latest qtr revenue 44.1% YoY, PAT 107.7% YoY; 4Y CAGR revenue 15.0% / PAT 20.5%; ROCE 21.0%; debt trend falling; OCF/PAT 1.13.
Sector strength 92.61
Quantitative valuation not in dossier — defer to qualitative read.
Enter ₹8059-₹8206; stop ₹7506; signal STRONG_BUY.
📐 EPS ₹129.5 × 25x (quality growth) = ₹3,236 median
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Synthesised consensus view (no live broker feed): the name screens as a high-quality compounder; buy-side would likely weight momentum + sector rotation; watch for re-rating triggers around the next quarterly print. Confirm against live broker reports before sizing.
| Closei | ₹8206.50 (2026-08-21) |
| EMA 20/50/200i | ₹8058.62 / ₹7751.71 / ₹6673.10 |
| EMA50 slope (20d)i | 5.01% |
| RSI(14)i | 56.96 |
| ATR(14)i | ₹276.29 (3.37%) |
| 52W High / Lowi | ₹8775.50 / ₹4498.50 |
| From 52W highi | -6.5% |
| Returns 1M/3M/6M/1Yi | 6.9% / 11.0% / 28.5% / 62.7% |
| Vol vs 20d avgi | 0.38x |
| Piotroski F-scorei | 4 / 6 (approx) |
| Altman Z-scorei | 2.66 (Z′ approx) |
| Beneish M-scorei | -2.43 (low, simplified) |
| Forensic riski | low (derived) |
| ROE / ROCEi | 15.3% / 21.0% |
| Revenue growth (3Y)i | 15.0% (4Y CAGR) |
| PAT growth (3Y)i | 20.5% (4Y CAGR) |
| Debt / Equityi | 0.32 (computed) |
| Promoter holdingi | 27.1% |
| FII / DII holdingi | 23.7% / 28.5% |
| NPMi | 20.0% |
| EPSi | 129.46 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹8,206.5 |
| EPS (TTM proxy)i | 129.46 |
| P/E (Screener ratios) | 73.7x |
| P/E (derived price ÷ EPS) | 63.4x |
| Market cap (Screener) | ₹42,105 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹715.0 |
| Dividend yield | 0.2% |
| Sales (latest)i | ₹3,314 Cr (41.1% YoY) |
| PAT (latest)i | ₹664 Cr (129.8% YoY) |
| Net debt (3Y)i | ₹43 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹8,059 – ₹8,206 |
| Stop loss | ₹7,506 |
| Target 2M | ₹9,035 |
| Target 4M | ₹9,588 |
| Target 6M | ₹11,026 |
| Reward / Risk (4M) | 1.97× |
| Reward / Risk (6M) | 4.03× |
| Risk per share | ₹700 |
| Suggested position size | 8% of portfolio |
Risk score breakdown: ATR 3.4% (+1.5)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 1045 | 34 | 243 | 47.43 |
| Mar 2026 | 938 | 34 | 213 | 41.48 |
| Dec 2025 | 892 | 34 | 185 | 36.18 |
| Sep 2025 | 758 | 32 | 148 | 28.96 |
Rev QoQ +11.4% · YoY +44.1% · PAT QoQ +14.1% · YoY +107.7% · OPM vs 4Q avg +417 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 3634 | 34 | 790 | 154.05 |
| Mar 2026 | 3314 | 33 | 664 | 129.46 |
| Mar 2025 | 2349 | 23 | 289 | 58.19 |
| Mar 2024 | 2065 | 19 | 270 | 54.56 |
| Mar 2023 | 2077 | 26 | 375 | 75.68 |
4Y CAGR — Revenue 15.0% · PAT 20.5% · EPS 19.4%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 1272 | 43 | 6379 |
| Mar 2025 | 1466 | 986 | 4830 |
| Mar 2024 | 1368 | 873 | 4377 |
Debt trend falling
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 894 | -1235 | -341 |
| Mar 2025 | 571 | -511 | 60 |
| Mar 2024 | 750 | -1094 | -344 |
OCF/PAT (latest FY) 1.13 → earnings quality: HIGH
Why selected: Stage 2 leader in top sector Chemicals & Specialty (strength=108), inv=78.7 · 7 positive · 0 negative factors flagged
Disclaimer: Not investment advice or a trading recommendation. Educational AI/rules-based market intelligence only. Use, replication, or trading action is at the user's own risk and legal obligation.
This report is provided strictly for educational, research, and learning purposes as part of a journey to understand how AI agents and rules-based agents can be applied to financial-market data. It is not investment advice, trading advice, portfolio advice, a research recommendation, or a solicitation to buy, sell, hold, short, or otherwise transact in any security, derivative, index, fund, or financial instrument. The information, scores, signals, narratives, charts, model outputs, and examples in this report must not be replicated, redistributed, automated, or used with any intent of trading, recommending trades, advising others, managing money, or making financial decisions. Anyone choosing to use, interpret, adapt, copy, replicate, distribute, or act on this information does so entirely at their own risk, responsibility, and legal and regulatory obligation. Agent Adda is not a SEBI-registered investment adviser, research analyst, portfolio manager, broker, or any other SEBI-registered market intermediary. Agent Adda, its creators, contributors, systems, agents, and associated persons accept no responsibility or liability for losses, damages, legal consequences, regulatory consequences, tax consequences, opportunity costs, or any other implications arising directly or indirectly from the use of this information by any person or organization. All market data can be delayed, incomplete, inaccurate, stale, or affected by corporate actions, liquidity, data-provider issues, model limitations, prompt limitations, or rule-design limitations. Users must consult qualified SEBI-registered professionals and independently verify all facts before making any financial or legal decision.